These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7238423)

  • 1. Bioavailability of norethindrone in rabbits after administration of norethindrone acetate in single, double and quadruple doses released through subcutaneous silastic implants.
    Sarkar NN; Laumas V; Laumas KR
    Endocrinol Jpn; 1980 Oct; 27(5):653-8. PubMed ID: 7238423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of norethindrone and menstrual pattern after insertion of norethindrone acetate implants in rhesus monkeys.
    Jha P; Murugesan K; Farooq A
    Contraception; 1991 Sep; 44(3):327-34. PubMed ID: 1764947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
    Laumas V; Jain AK; Jha P; Rahman SA; Kumar D; Malik BK; Sarkar NN; Takkar D; Hingorani V; Laumas KR
    Contraception; 1981 Feb; 23(2):211-25. PubMed ID: 6786828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate.
    Singh H; Uniyal JP; Jha P; Takker D; Murguesan K; Hingorani V; Laumas KR
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):302-8. PubMed ID: 7058686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of norethindrone : serum levels of norethindrone in lactating women after insertion of a single Silastic implant releasing norethindrone acetate.
    Laumas V; Malik BK; Jamal K; Seth U; Agarwal N; Hingorani V; Laumas KR
    Contraception; 1978 Dec; 18(6):593-605. PubMed ID: 750187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate.
    Hillier SG; Jha P; Griffiths K; Laumas KR
    Contraception; 1977 Apr; 15(4):473-88. PubMed ID: 880821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of norethisterone in women with subcutaneous implants of norethisterone acetate.
    Joshi JV; Naik VK; Joshi UM
    Indian J Med Res; 1979 Oct; 70():625-31. PubMed ID: 541006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.
    Toddywalla VS; Mehta S; Virkar KD; Saxena BN
    Contraception; 1980 Mar; 21(3):217-23. PubMed ID: 7389350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
    Wide L; Naessén T; Eriksson K; Rune C
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate.
    Sarkar NN; Laumas V; Agarwal N; Hingorani V; Laumas KR
    Acta Obstet Gynecol Scand; 1983; 62(1):71-6. PubMed ID: 6858629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid-filled silastic capsules : a new approach to a more constant steroidal drug delivery system.
    Kumar D; Farooq A; Laumas KR
    Contraception; 1981 Mar; 23(3):261-8. PubMed ID: 7238045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local tissue response to silastic implant containing norethindrone acetate in women.
    Jeyaseelan S; Takkar D; Bhuyan UN; Laumas KR; Hingorani V
    Contraception; 1977 Jan; 15(1):39-51. PubMed ID: 880802
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
    Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
    Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum norethindrone levels and menstrual pattern after the use of norethindrone implants in rhesus monkeys.
    Jha P; Murugesan K; Farooq A
    Contraception; 1995 Feb; 51(2):117-20. PubMed ID: 7750289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women.
    Bhatnagar S; Srivastava UK; Takkar D; Chandra VL; Hingorani V; Laumas KR
    Contraception; 1975 May; 11(5):505-21. PubMed ID: 1139938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
    Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
    Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone.
    Odlind V; Weiner E; Johansson ED
    Contraception; 1979 Feb; 19(2):197-206. PubMed ID: 428235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the binding of two 19-nortestosterone derivatives to human serum albumin: insights into the interactions of steroid hormone drugs with functional biomacromolecule.
    He J; Wang Q; Ma X; Yang H; Li S; Xu K; Li H
    J Mol Recognit; 2016 Sep; 29(9):415-25. PubMed ID: 26940023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable norethindrone (NET:cholesterol) contraceptive implants: phase II-A: a clinical study in women.
    Singh M; Saxena BB; Raghubanshi RS; Ledger WJ; Harman SM; Leonard RJ
    Contraception; 1997 Jan; 55(1):23-33. PubMed ID: 9013058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of norethisterone enanthate subdermal silastic implants on luteal function in rabbits.
    Srivastava UK; Chowdhury SR
    Endokrinologie; 1982 Jul; 80(1):52-5. PubMed ID: 7173122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.